Skip to Main Content

Paper Details

Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic target.
Cancer Cell Int
26
2019
EGFR, KRAS, LGSC, LGSC cell lines, MAPK, MEK, MEKi, MEKi-resistant cell lines, MEKi-resistant lines, PKC-alpha, cancers, cell lines, low-grade serous ovarian cancer, ovarian cancer, ovarian cancer cell lines, patient, patients, tumor, tumors

Datasets

Release 1.2